Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
---|
03/31/1998 | US5734022 Antibodies to a novel mammalian protein associated with uncontrolled cell division |
03/31/1998 | US5734021 Having an amino acid sequence as set forth as seq id #2; genetic engineering |
03/31/1998 | US5734019 Hepatitis C virus antigen polypeptide, production method therefor, and antibody detection method |
03/31/1998 | US5734016 Genetic engineering |
03/31/1998 | US5734015 Antibiotics |
03/31/1998 | US5734014 Polypeptide |
03/31/1998 | US5734012 Cyclic motilin-like polypeptides with gastrointestinal motor stimulating activity |
03/31/1998 | US5733879 Peptides and proteins, process for their preparation and their use as cholesterol acceptors |
03/31/1998 | US5733878 Morphogen-induced periodontal tissue regeneration |
03/31/1998 | US5733877 Pharmaceutical composition containing biologically active peptide or protein |
03/31/1998 | US5733876 Method of inhibiting angiogenesis |
03/31/1998 | US5733874 Stable dry powders |
03/31/1998 | US5733873 Polyoxamers or polyoxyethylene sorbitan fatty acid esters with sodium chloride, calcium chloride, histidine or sugars |
03/31/1998 | US5733872 Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
03/31/1998 | US5733790 CRF binding protein antibodies and assays using same |
03/31/1998 | US5733780 Construction of Pasteurella haemolytica vaccines |
03/31/1998 | US5733778 Vaccines, medical diagnosis |
03/31/1998 | US5733772 Cloning and expression of Plasmodium falciparum transmission blocking target antigen, Pfs230 |
03/31/1998 | US5733771 cDNAs encoding minor ampullate spider silk proteins |
03/31/1998 | US5733768 Amyloid precursor protein protease |
03/31/1998 | US5733765 A polypeptide producing a heteropolysaccharide |
03/31/1998 | US5733761 Gene therapy |
03/31/1998 | US5733760 Salmonella vectors encoding truncated pag fusion protein, method of making, and uses thereof |
03/31/1998 | US5733748 Isolated polynucleotide; cancer diagnosis |
03/31/1998 | US5733745 Pure genetic engineered protein |
03/31/1998 | US5733740 Taga gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma |
03/31/1998 | US5733730 Telomere repeat binding factor and diagnostic and therapeutic use thereof |
03/31/1998 | US5733727 Myocardial grafts and cellular compositions |
03/31/1998 | US5733556 Newcastle disease virus combination vaccine |
03/31/1998 | US5733554 Avian herpesvirus-based live recombinant avian vaccine, in particular against Gumboro disease |
03/31/1998 | US5733553 Nucleotide sequence |
03/31/1998 | US5733549 Peptides including amino acid sequences selected from lipoprotein (a) and apolipoprotein (a), antibodies recognizing these amino acid sequences, and methods of determination using these antibodies |
03/31/1998 | US5733548 Stimulating t-cell response |
03/31/1998 | US5733547 Treatment of autoimmune arthritis by oral administration of type I or type III collagen |
03/31/1998 | US5733546 Immunochemical detection of in vivo advanced glycosylation endproducts |
03/31/1998 | US5733543 Genetic engineering; delaying acquired immune deficiency syndrome (aids) onset |
03/31/1998 | US5733541 Hematopoietic cells: compositions and methods |
03/31/1998 | US5733540 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
03/31/1998 | US5733538 Surface-modifying copolymers having cell adhesion properties |
03/31/1998 | CA2134889C Calcium channel blocking polypeptides from filistata hibernalis |
03/31/1998 | CA2040441C Fusion proteins |
03/31/1998 | CA1339793C Cyclic analogs of atrial natriuretic peptides |
03/31/1998 | CA1339792C Purification of hepatitis proteins |
03/31/1998 | CA1339791C Human nerve growth factor |
03/31/1998 | CA1339782C Fluorescent conjugates and biological diagnostic assay |
03/26/1998 | WO1998012563A1 Method to detect dirofilaria immitis infection |
03/26/1998 | WO1998012562A1 Adhesins from heliobacter pylori and their diagnostic and therapeutic uses |
03/26/1998 | WO1998012558A1 Methods for in vitro determination of erythropoietin bioactivity |
03/26/1998 | WO1998012347A1 Rh blood group antigen compositions and methods of use |
03/26/1998 | WO1998012344A1 Human tumor necrosis factor receptor-like genes |
03/26/1998 | WO1998012339A2 Viral vectors and their uses |
03/26/1998 | WO1998012335A1 Nematode-resistant gene |
03/26/1998 | WO1998012333A1 Immunogenic peptides of foot-and-mouth disease viruses |
03/26/1998 | WO1998012332A1 Compositions and methods for treating intracellular diseases |
03/26/1998 | WO1998012331A1 Novel polypeptide originating in hemophilus paragallinarum and process for producing the same |
03/26/1998 | WO1998012330A1 Mammalian cytokine, related reagents |
03/26/1998 | WO1998012328A2 Human bad polypeptides, encoding nucleic acids and methods of use |
03/26/1998 | WO1998012327A2 Compositions and methods comprising bard1 and other brca1 binding proteins |
03/26/1998 | WO1998012326A1 Hedgehog interacting proteins and uses related thereto |
03/26/1998 | WO1998012325A1 Human gtp binding protein gamma-3 |
03/26/1998 | WO1998012324A1 Monocyte chemotactic protein 5 (mcp-5) molecules and uses therefor |
03/26/1998 | WO1998012323A1 Nucleic acid encoding congenital heart disease protein and products related thereto |
03/26/1998 | WO1998012322A1 Bone morphogenetic protein-16 (bmp-16) compositions |
03/26/1998 | WO1998012321A1 Recombinant plant cells expressing heterochromatin 1 (hp1) of drosophila melanogaster |
03/26/1998 | WO1998012320A1 Nucleic acid construct coding for a protein complex from a stat protein and a nuclear receptor and its use |
03/26/1998 | WO1998012319A1 Broad spectrum therapeutic peptide |
03/26/1998 | WO1998012318A1 Thrombin inhibitor |
03/26/1998 | WO1998012317A1 Metalocarboxypeptidase inhibitors and derived molecules used as antitumor agents |
03/26/1998 | WO1998012309A2 Method of cell surface activation and inhibition |
03/26/1998 | WO1998012308A1 Soluble polypeptides with activity of the ns3 serine protease of hepatitis c virus, and process for their preparation and isolation |
03/26/1998 | WO1998012306A1 Hematopoietic stem cells and methods for generating such cells |
03/26/1998 | WO1998012305A1 A method of stable integration of dna into neurons |
03/26/1998 | WO1998012302A1 Weight control pathway genes and uses therefor |
03/26/1998 | WO1998012274A1 Methods and devices for preparing protein concentrates |
03/26/1998 | WO1998012226A1 Methods of ameliorating cancer and of inhibiting angiogenesis by using fibronectin |
03/26/1998 | WO1998012225A2 Process for producing a plasma protein-containing medicament |
03/26/1998 | WO1998012224A1 Use of leptin antagonists for treating insulin resistance in type ii diabetes |
03/26/1998 | WO1998012223A1 Novel human interferon-inducible protein |
03/26/1998 | WO1998012222A1 Casein and process for the preparation thereof |
03/26/1998 | WO1998012221A1 Peptide as diagnostic and therapeutic agent for autoimmune diseases |
03/26/1998 | WO1998012220A2 Novel tumor proteins |
03/26/1998 | WO1998012212A1 Nucleopeptide complexes, cosmetic and pharmaceutical compositions containing them and their uses |
03/26/1998 | WO1998012208A1 Heat shock protein complexes |
03/26/1998 | WO1998012207A1 High level expression of proteins |
03/26/1998 | WO1998012205A1 Ivi-2, ivi-3 and ivi-4 loci of enterococcus faecalis polynucleotide, polypeptides and method of use therefor |
03/26/1998 | WO1998012204A1 Human b-cell translocation genes-2 and 3 |
03/26/1998 | WO1998011925A1 Process of preparation of an autologous fibrin glue |
03/26/1998 | WO1998011917A1 Hiv-1 therapy with il-2 and anti-tnf antibody |
03/26/1998 | WO1998011916A1 Viral defective interfering particles and uses thereof |
03/26/1998 | WO1998011915A1 Strain selection of pneumococcal surface proteins |
03/26/1998 | WO1998011914A1 Targeting antigens to the mhc class i processing pathway with anthrax toxin fusion protein |
03/26/1998 | WO1998011909A1 Use of proteins as agents against autoimmune diseases |
03/26/1998 | WO1998011907A1 Peptide inhibitors of nuclear protein translocation having nuclear localization sequences and methods of use thereof |
03/26/1998 | WO1998011779A1 Delivery of therapeutic gene products by intestinal cell expression |
03/26/1998 | WO1998007830A3 COMPLETE GENOME SEQUENCE OF THE METHANOGENIC ARCHAEON, $i(METHANOCOCCUS JANNASCHII) |
03/26/1998 | WO1998006827A3 Method for immortalizing cells |
03/26/1998 | WO1998004589A3 Production of recombinant plasma gelsolin containing a disulfide bond |
03/26/1998 | WO1998003655A3 Gene expression regulatory dna, expression cassette, expression vector and transgenic plant |
03/26/1998 | WO1998003538A3 Signal-regulated, cleavage-mediated toxins |
03/26/1998 | WO1998000695A3 Tat-sf: cofactor for stimulation of transcriptional elongation by hiv-1 tat |